IPP Bureau
Merck’s pembrolizumab demonstrates improvement in distant metastasis
By IPP Bureau - June 06, 2022
Immune-mediated events and infusion reactions were higher with KEYTRUDA (38% vs 9%, respectively).
India ready for playing global role to provide healthcare services: Mandaviya
By IPP Bureau - June 06, 2022
India is at a key inflexion point of not just ‘Heal in India’ through its vibrant medical value tourism, but also ‘Heal by India’, where our medical professionals can be used to serve not just our country but at the global level.
AstraZeneca’s Pascal Soriot awarded British knighthood for services to UK
By IPP Bureau - June 04, 2022
AstraZeneca also played a critical role in the global response to COVID-19.
Susanne Kaestner and Thea Boehm join ProBioGen
By IPP Bureau - June 04, 2022
Susanne Kaestner joins the company as Senior Vice President, Quality and member of the Executive Team, and Dr. Thea Boehm as Vice President, Business Development.
C2i Genomics and Karkinos Healthcare partner to bring AI-powered cancer detection and monitoring to India
By IPP Bureau - June 04, 2022
C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India
Organon introduces global ESG strategy
By IPP Bureau - June 04, 2022
Report lays out blueprint for achieving Organon’s purpose and business imperatives to help women and girls achieve their promise through better health
Israeli researchers create sperm on a chip
By IPP Bureau - June 04, 2022
A research group led by Ben-Gurion University of the Negev managed to produce an innovative microchip for creating sperm in a culture by using a microfluidic system.
Phygital model of med-tech seems to be quite Promising: opines Expert
By IPP Bureau - June 04, 2022
To address the preventive & primary healthcare delivery gaps in India
Indian pharma market to grow at a CAGR of 12.3% to US$130 bn
By IPP Bureau - June 04, 2022
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
Innate Pharma announces IPH5201 phase 2 study in lung cancer
By IPP Bureau - June 04, 2022
Innate to receive $5M milestone payment from AstraZeneca
Fortis Healthcare opens Healthcare Information Centre at Tirupati
By IPP Bureau - June 04, 2022
The information center has been established with the aim of providing Fortis Healthcare’s world-class healthcare services accessible to the people of Tirupati.
RH Capital announces investments to improve women’s health
By IPP Bureau - June 04, 2022
RH Capital, a leading women's health venture capital fund, announced three new investments to improve health outcomes for women in the US.
LEO Pharma strengthens its commercial organization
By IPP Bureau - June 03, 2022
The refocused commercial set-up will increase organizational efficiency and alignment across all commercial functions globally
CMP Pharma announces calcium channel blocker ‘Norliqva’ availability
By IPP Bureau - June 03, 2022
Norliqva was approved by the FDA on February 24, 2022 and is now available through normal retail distribution.
Lockwood acquires medical animation studio ‘Random42’ from Graphite Capital
By IPP Bureau - June 03, 2022
The partnership between Lockwood and Random42 expands the capabilities and geographic footprint for both organizations.
